Page last updated: 2024-08-25

clarithromycin and cem 101

clarithromycin has been researched along with cem 101 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Castanheira, M; Jones, RN; Woosley, LN	1
Higuchi, K; Inoue, K; Kishimoto, H; Kiyomiya, K; Saito, N; Shirasaka, Y; Takada, T; Tomabechi, R; Watai, K	1

Other Studies

2 other study(ies) available for clarithromycin and cem 101

Article	Year
CEM-101 activity against Gram-positive organisms. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Gentamicins; Gram-Positive Bacteria; Ketolides; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin	2010
Macrolide and Ketolide Antibiotics Inhibit the Cytotoxic Effect of Trastuzumab Emtansine in HER2-Positive Breast Cancer Cells: Implication of a Potential Drug-ADC Interaction in Cancer Chemotherapy. Molecular pharmaceutics, 2023, Dec-04, Volume: 20, Issue:12 Topics: Ado-Trastuzumab Emtansine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Azithromycin; Breast Neoplasms; Clarithromycin; Female; Humans; Immunoconjugates; Ketolides; Lysosomes; Maytansine; Receptor, ErbB-2; Trastuzumab	2023

Article

Year

CEM-101 activity against Gram-positive organisms.

Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Gentamicins; Gram-Positive Bacteria; Ketolides; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

2010

Macrolide and Ketolide Antibiotics Inhibit the Cytotoxic Effect of Trastuzumab Emtansine in HER2-Positive Breast Cancer Cells: Implication of a Potential Drug-ADC Interaction in Cancer Chemotherapy.

Molecular pharmaceutics, 2023, Dec-04, Volume: 20, Issue:12

Topics: Ado-Trastuzumab Emtansine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Azithromycin; Breast Neoplasms; Clarithromycin; Female; Humans; Immunoconjugates; Ketolides; Lysosomes; Maytansine; Receptor, ErbB-2; Trastuzumab

2023